Do You Think the FDA Will Approve Yet Another Alzheimer's Drug?

E-Sci and Biogen's next Alzheimer's drug. The FDA is expected to approve yet another Alzheimer's treatment, this one with a connection to Biogen in the form of Lacanum app. It has the same underlying scientific theory as to how to treat Alzheimer's but is a completely different drug from Adju Helm. But nonetheless, the world has just gotten to see a book length rebuke basically of how the FDA reviewed the last Alzheimer's drugs.